G. Sagnella

发表

Double-blind randomised trial of modest salt restriction in older people

F. Cappuccio, N. Markandu, C. Carney, 1997, The Lancet.

Variant of SCN5A Sodium Channel Implicated in Risk of Cardiac Arrhythmia

F. Cappuccio, A. Beggs, R. Kass, 2002, Science.

Plasma sodium: ignored and underestimated.

N. Markandu, G. Sagnella, G. MacGregor, 2004, Hypertension.

Plasma Sodium: Ignored and Underestimated

N. Markandu, G. Sagnella, G. MacGregor, 2005 .

Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-independent or dialysis-dependent chronic renal failure.

N. Markandu, G. Sagnella, G. MacGregor, 1992, Clinical science.

Measurement and importance of plasma brain natriuretic peptide and related peptides

G. Sagnella, G A Sagnella, 2001, Annals of clinical biochemistry.

Atrial natriuretic peptide mimetics and vasopeptidase inhibitors.

G. Sagnella, 2001, Cardiovascular research.

In-vivo intracellular pH at rest and during exercise in patients with essential hypertension

J. Griffiths, D. McIntyre, N. Markandu, 2001, Journal of hypertension.

Contrasting endocrine responses to acute oral compared with intravenous sodium loading in normal humans.

N. Markandu, G. Sagnella, G. MacGregor, 1998, American journal of physiology. Renal physiology.

Lack of association of ACE/angiotensinogen genotype with renal function in autosomal dominant polycystic kidney disease.

G. Sagnella, G. MacGregor, S. Jeffery, 2000, Genetic testing.

Plasma concentrations and comparisons of brain and atrial natriuretic peptide in normal subjects and in patients with essential hypertension.

N. Markandu, G. Sagnella, G. MacGregor, 1993, Journal of human hypertension.

RAISED CIRCULATING LEVELS OF ATRIAL NATRIURETIC PEPTIDES IN ESSENTIAL HYPERTENSION

A. Shore, N. Markandu, G. Sagnella, 1986, The Lancet.

Platelet sodium-hydrogen exchanger activity and left ventricular mass

N. Markandu, G. Sagnella, G. MacGregor, 2001, Journal of Human Hypertension.

MODERATE POTASSIUM SUPPLEMENTATION IN ESSENTIAL HYPERTENSION

N. Markandu, G. Sagnella, G. MacGregor, 1982, The Lancet.

DOUBLE-BLIND RANDOMISED CROSSOVER TRIAL OF MODERATE SODIUM RESTRICTION IN ESSENTIAL HYPERTENSION

N. Markandu, G. Sagnella, G. MacGregor, 1982, The Lancet.

N-terminal atrial natriuretic peptide and atrial natriuretic peptide in human plasma: investigation of plasma levels and molecular circulating form(s) using radioimmunoassays for pro-atrial natriuretic peptide (31-67), pro-atrial natriuretic peptide (1-30) and atrial natriuretic peptide (99-126).

N. Markandu, G. Sagnella, G. MacGregor, 1994, Clinical science.

Concentrations of N-terminal ProANP in human plasma: evidence for ProANP (1-98) as the circulating form.

N. Markandu, G. Sagnella, G. MacGregor, 1990, Clinica chimica acta; international journal of clinical chemistry.

Urinary Protein and Essential Hypertension in Black and in White People

N. Markandu, G. Sagnella, G. MacGregor, 2002, Hypertension.

Evidence for increased levels of a circulating ouabainlike factor in essential hypertension.

A. Shore, N. Markandu, G. Sagnella, 1986, Hypertension.

Variable effects of the APOC3 –482C > T variant on insulin, glucose and triglyceride concentrations in different ethnic groups

K. Alberti, F. Cappuccio, D. Waterworth, 2001, Diabetologia.

Angiotensin converting enzyme gene I/D polymorphism, blood pressure and the renin-angiotensin system in Caucasian and Afro-Caribbean peoples.

F. Cappuccio, N. Markandu, G. Sagnella, 1996, Journal of human hypertension.

Angiotensinogen Met235-->Thr polymorphism in a London normotensive and hypertensive black and white population.

N. Markandu, G. Sagnella, G. MacGregor, 1994, Journal of human hypertension.

with intravenous sodium loading in normal humans Contrasting endocrine responses to acute oral compared

N. Markandu, G. Sagnella, G. MacGregor, 2016 .

Ethnic differences in fibrinogen levels: the role of environmental factors and the beta-fibrinogen gene.

D. Cook, S. Humphries, F. Cappuccio, 2001, American journal of epidemiology.

Effect of beta blockade on the neurohumoral and cardiopulmonary response to dynamic exercise in cardiac transplant recipients.

N. Markandu, G. Sagnella, G. MacGregor, 1994, British heart journal.

Importance of the renin system in determining blood pressure fall with salt restriction in black and white hypertensives.

N. Markandu, G. Sagnella, G. MacGregor, 1998, Hypertension.

Plasma immunoreactive atrial natriuretic peptide and changes in dietary sodium intake in man.

A. Shore, N. Markandu, G. Sagnella, 1987, Life sciences.

Raised plasma levels of atrial natriuretic peptides in Addison’s disease

F. Cappuccio, N. Markandu, G. Sagnella, 1989, Journal of endocrinological investigation.

Brain and atrial natriuretic peptides: a dual peptide system of potential importance in sodium balance and blood pressure regulation in patients with essential hypertension

N. Markandu, G. Sagnella, G. MacGregor, 1994, Journal of hypertension.

Moderate potassium chloride supplementation in essential hypertension: is it additive to moderate sodium restriction?

N. Markandu, G. Sagnella, G. MacGregor, 1985, British medical journal.

Immunoreactive N-terminal pro-atrial natriuretic peptide in human plasma: plasma levels and comparisons with alpha-human atrial natriuretic peptide in normal subjects, patients with essential hypertension, cardiac transplant and chronic renal failure.

N. Markandu, G. Sagnella, G. MacGregor, 1989, Clinical science.

Practical implications of current natriuretic peptide research

G. Sagnella, Giuseppe A Sagnella, 2000, Journal of the renin-angiotensin-aldosterone system : JRAAS.

Hormonal and renal responses to neutral endopeptidase inhibition in normal humans on a low and on a high sodium intake

N. Markandu, G. Sagnella, G. MacGregor, 1995, European journal of clinical investigation.

Atrial natriuretic peptides in essential hypertension: basal plasma levels and relationship to sodium balance.

F. Cappuccio, N. Markandu, G. Sagnella, 1991, Canadian journal of physiology and pharmacology.

Glucose load and renal sodium handling in mild essential hypertension on different sodium intakes.

F. Cappuccio, N. Markandu, G. Sagnella, 1996, Journal of human hypertension.

Cardiac Transplant Recipients

N. Markandu, G. Sagnella, M. Miller, 2005 .

Blood pressure and endocrine responses to changes in dietary sodium intake in cardiac transplant recipients. Implications for the control of sodium balance.

M. Yacoub, F. Cappuccio, N. Markandu, 1994, Circulation.

[Moderate supplementation of potassium in essential hypertension].

N. Markandu, G. Sagnella, G. MacGregor, 1984, Archives des maladies du coeur et des vaisseaux.

116 A double‐blind study of three sodium intakes, and the long- term effects of sodium restriction in essential hypertension

F. Cappuccio, N. Markandu, G. Sagnella, 1988 .

Direct renin assay and plasma renin activity assay compared.

G. Sagnella, G. MacGregor, C. Chesters, 2004, Clinical chemistry.

Contrasting associations between aldosterone synthase gene polymorphisms and essential hypertension in blacks and in whites

A. Onipinla, Yanbin Dong, Haidong Zhu, 2003, Journal of hypertension.

Does a diuretic cause a further fall in blood pressure in hypertensive patients already on nifedipine?

F. Cappuccio, N. Markandu, G. Sagnella, 1986, The Journal of Clinical Hypertension.

Sodium restriction lowers high blood pressure through a decreased response of the renin system--direct evidence using saralasin.

F. Cappuccio, N. Markandu, G. Sagnella, 1985, Journal of hypertension.

Angiotensin converting enzyme inhibition reveals an important role for the renin system in the control of normal and high blood pressure in man.

N. Markandu, G. Sagnella, G. MacGregor, 1983, Clinical and experimental hypertension. Part A, Theory and practice.

Plasma atrial natriuretic peptide in essential hypertension: effects of changes in dietary sodium.

A. Shore, N. Markandu, G. Sagnella, 1987, British medical journal.

Dietary Sodium Restriction in Normotensive Subjects and Patients with Essential Hypertension

N. Markandu, G. Sagnella, G. MacGregor, 1982 .

Increased numbers of alpha receptors in sympathetic denervation supersensitivity in man.

C. Mathias, P. Sever, G. Sagnella, 1982, The Journal of clinical investigation.

Is atrial natriuretic peptide-guanosine 3',5' cyclic monophosphate coupling a determinant of urinary sodium excretion in essential hypertension?

N. Markandu, G. Sagnella, G. MacGregor, 1992, Journal of hypertension.

Atrial natriuretic peptide--cyclic GMP coupling and urinary sodium excretion during acute volume expansion in man.

P. Hamet, J. Tremblay, N. Markandu, 1990, Canadian journal of physiology and pharmacology.

Circulating soluble E-selectin levels and the Ser 128Arg polymorphism in individuals from different ethnic groups.

D. Cook, F. Cappuccio, S. Kerry, 2005, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Dietary Sodium and Inhibition of Neutral Endopeptidase 24.11 in Essential Hypertension

N. Markandu, G. Sagnella, G. MacGregor, 1991, Hypertension.

Stability of atrial natriuretic peptide during storage at -20 degrees C.

G. Sagnella, G. MacGregor, M. Buckley, 1996, Journal of human hypertension.

Plasma Concentrations and Comparisons of Brain Natriuretic Peptide and Atrial Natriuretic Peptide in Normal Subjects, Cardiac Transplant Recipients and Patients with Chronic Renal Failure

N. Markandu, G. Sagnella, G. MacGregor, 1992 .

N-terminal pro atrial natriuretic peptide in human plasma.

N. Markandu, G. Sagnella, G. MacGregor, 1990, American journal of hypertension.

Plasma atrial natriuretic peptide in essential hypertension. Comparison with normotensive subjects and effects of changes in dietary sodium intake.

A. Shore, N. Markandu, G. Sagnella, 1988, American journal of hypertension.

Plasma atrial natriuretic peptide: its relationship to changes in sodium intake, plasma renin activity and aldosterone in man.

A. Shore, M. Forsling, N. Markandu, 1987, Clinical science.

Association between atrial natriuretic peptide and cyclic GMP in hypertension and in chronic renal failure.

N. Markandu, G. Sagnella, G. MacGregor, 1998, Clinica chimica acta; international journal of clinical chemistry.

Association between extracellular volume expansion and urinary calcium excretion in normal humans

F. Cappuccio, N. Markandu, G. Sagnella, 1993, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

Serum Ionized Calcium and pH: Effects of Blood Storage, Some Physiological Influences and a Comparison Between Normotensive and Hypertensive Subjects

A. Shore, N. Markandu, G. Sagnella, 1987, Journal of hypertension.

Changes in the plasma levels of atrial natriuretic peptides during mineralocorticoid escape in man.

A. Shore, F. Cappuccio, N. Markandu, 1987, Clinical science.

Properties of a renin inhibitor isolated from the pig kidney cortex.

G. Sagnella, W. Peart, 1981, Clinical science.

Does potassium lower blood pressure by increasing sodium excretion? A metabolic study in patients with mild to moderate essential hypertension.

L. Poston, N. Markandu, G. Sagnella, 1983, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

Angiotensin II suppression is a major factor permitting excretion of an acute sodium load in humans.

N. Markandu, G. Sagnella, G. MacGregor, 1994, The American journal of physiology.

Physiology: Cardiac peptides and the control of sodium excretion

G. Sagnella, G. MacGregor, G. Macgregor, 1984, Nature.

KINCALC: by S. W. Orchard, Elsevier-BIOSOFT, 1984. $30.00/£18.00

G. Sagnella, 1985 .

POTASSIUM SUPPLEMENTS AND HYPERTENSION

A. Silman, N. Markandu, G. Sagnella, 1984, The Lancet.

in Black and White Hypertensives Importance of the Renin System in Determining Blood Pressure Fall With Salt Restriction

N. Markandu, G. Sagnella, G. MacGregor, 2013 .

Platelet sodium/hydrogen exchanger activity in normotensives and hypertensives.

G. Sagnella, G. MacGregor, M. Miller, 1999, Clinica chimica acta; international journal of clinical chemistry.

Angiotensin converting enzyme insertion/deletion polymorphism: association with ethnic origin

G. Sagnella, J. Cruickshank, S. Jeffery, 1994, Journal of hypertension.

Ethnic differences in erythrocyte membrane fluidity and the association with serum triacylglycerols.

N. Markandu, G. Sagnella, G. MacGregor, 2001, Clinical science.

Association studies of genetic polymorphisms and complex disease

F. Cappuccio, G. Sagnella, G. MacGregor, 2000, The Lancet.

A diuretic is more effective than a beta-blocker in hypertensive patients not controlled on amlodipine and lisinopril.

F. Cappuccio, N. Markandu, G. Sagnella, 1996, Hypertension.

Kinetics of renal sodium excretion during changes in dietary sodium intake in man--an exponential process?

N. Markandu, G. Sagnella, G. MacGregor, 1990, Clinical and experimental hypertension. Part A, Theory and practice.

Hormonal responses to gradual changes in dietary sodium intake in humans.

N. Markandu, G. Sagnella, G. MacGregor, 1989, The American journal of physiology.

Modest salt restriction in older people

F. Cappuccio, N. Markandu, C. Carney, 1997, The Lancet.

Vasopeptidase inhibitors.

G. Sagnella, 2002, Journal of the renin-angiotensin-aldosterone system : JRAAS.

Plasma aldosterone: comparison of a new automated assay with a standard extraction method.

G. Sagnella, G. MacGregor, T. Doulton, 2006, Clinical chemistry.

Molecular variants of the sodium/hydrogen exchanger type 3 gene and essential hypertension

A. Onipinla, Yanbin Dong, Haidong Zhu, 2004, Journal of hypertension.

A double-blind crossover study of the effect of concomitant diuretic therapy in hypertensive patients treated with amlodipine.

F. Cappuccio, N. Markandu, G. Sagnella, 1991, American journal of hypertension.

Captopril: contrasting effects of adding hydrochlorothiazide, propranolol, or nifedipine.

N. Markandu, G. Sagnella, G. MacGregor, 1985, Journal of cardiovascular pharmacology.

Evidence using human arterial tissue for a circulating vascular sensitizing agent in essential hypertension.

F. Cappuccio, N. Markandu, G. Sagnella, 1986, The Journal of clinical endocrinology and metabolism.

Angiotensin converting enzyme insertion/deletion polymorphism

G. Sagnella, J. Cruickshank, S. Jeffery, 1994 .

Effect of a single test dose of lithium carbonate on sodium and potassium excretion in man.

N. Markandu, G. Sagnella, G. MacGregor, 1991, Clinical science.

Endocrine and renal response to water loading and water restriction in normal man.

A. Shore, M. Forsling, N. Markandu, 1988, Clinical science.

Prolonged decrease in blood pressure after atrial natriuretic peptide infusion in essential hypertension: a new anti-pressor mechanism?

N. Markandu, G. Sagnella, G. MacGregor, 1989, Clinical science.

Radioimmunoassay for plasma neuropeptide-Y in physiological and physiopathological states and response to sympathetic activation.

N. Markandu, G. Sagnella, G. MacGregor, 1990, Clinica chimica acta; international journal of clinical chemistry.

Extraction method and nonextracted kit method compared for measuring plasma aldosterone.

G. Sagnella, G. MacGregor, M. Miller, 1997, Clinical chemistry.

Secretion of atrial natriuretic peptide from the heart in man.

G. Sagnella, G. MacGregor, D. Singer, 1987, British heart journal.

Acute and sustained changes in sodium balance during nifedipine treatment in essential hypertension.

F. Cappuccio, N. Markandu, G. Sagnella, 1991, The American journal of medicine.

Renal tubular sodium handling and plasma atrial natriuretic peptide, renin activity and aldosterone in untreated men under normal living conditions

F. Cappuccio, M. Mancini, E. Farinaro, 1991, European journal of clinical investigation.

Atrial natriuretic peptide in human plasma--comparison of radioreceptor versus radioimmunoassay.

N. Markandu, G. Sagnella, G. MacGregor, 1987, Clinica chimica acta; international journal of clinical chemistry.

Subcellular Distribution and Storage Form of Rat Renal Renin

G. Sagnella, R. Price, W. Peart, 1980, Hypertension.

Subcellular distribution of multiple forms of acid p-nitrophenyl phosphatase in rat kidney.

G. Sagnella, R. G. Price, W. Peart, 1980, The International journal of biochemistry.

Plasma atrial natriuretic peptide, aldosterone, and plasma renin activity responses to gradual changes in dietary sodium intake.

N. Markandu, G. Sagnella, G. MacGregor, 1990, American journal of hypertension.

Moderate sodium restriction with angiotensin converting enzyme inhibitor in essential hypertension: a double blind study.

A. Shore, F. Cappuccio, N. Markandu, 1987, British medical journal.

DOUBLE-BLIND STUDY OF THREE SODIUM INTAKES AND LONG-TERM EFFECTS OF SODIUM RESTRICTION IN ESSENTIAL HYPERTENSION

F. Cappuccio, N. Markandu, G. Sagnella, 1989, The Lancet.

Distribution of β‐endorphin in normal and schizophrenic human brains

S. Lightman, E. Bird, G. Sagnella, 1979 .

Lack of effect of captopril on the sodium retention of the nephrotic syndrome.

E. Brown, N. Markandu, G. Sagnella, 1984, Nephron.

Does Nifedipine Reveal a Functional Abnormality of Arteriolar Smooth Muscle Cell in Essential Hypertension—The Effect of Altering Sodium Balance

N. Markandu, G. Sagnella, G. MacGregor, 1985, Journal of cardiovascular pharmacology.

Sodium retention in nephrotic syndrome is due to an intrarenal defect: evidence from steroid-induced remission.

E. Brown, N. Markandu, G. Sagnella, 1985, Nephron.

Relationship between the M235T and G(-6)A polymorphisms of the angiotensinogen gene

A. Onipinla, G. Sagnella, G. MacGregor, 1999, Journal of Human Hypertension.

Association between the C825T polymorphism of the G protein beta3-subunit gene and hypertension in blacks.

D. Cook, H. Zhu, F. Cappuccio, 1999, Hypertension.

Review: Vasopeptidase inhibitors

G. Sagnella, 2002 .

A population study of ethnic variations in the angiotensin-converting enzyme I/D polymorphism: relationships with gender, hypertension and impaired glucose metabolism.

A. Onipinla, D. Cook, F. Cappuccio, 1999, Journal of hypertension.

Effect of Salt Intake on Renal Excretion of Water in Humans

N. Markandu, G. Sagnella, G. MacGregor, 2001, Hypertension.

EFFECTS OF CHANGES IN DIETARY SODIUM INTAKE AND SALINE INFUSION ON IMMUNOREACTIVE ATRIAL NATRIURETIC PEPTIDE IN HUMAN PLASMA

A. Shore, N. Markandu, G. Sagnella, 1985, The Lancet.

Modest Salt Reduction Reduces Blood Pressure and Urine Protein Excretion in Black Hypertensives: A Randomized Control Trial

N. Markandu, G. Sagnella, G. MacGregor, 2005, Hypertension.

Reduction of salt intake during converting enzyme inhibitor treatment compared with addition of a thiazide.

F. Cappuccio, N. Markandu, G. Sagnella, 1995, Hypertension.

Regulation of the epithelial sodium channel by accessory proteins.

Yanbin Dong, G. Sagnella, K. Gormley, 2003, The Biochemical journal.

The renal epithelial sodium channel: genetic heterogeneity and implications for the treatment of high blood pressure.

G. Sagnella, P. Swift, 2006, Current pharmaceutical design.

EVIDENCE THAT SOME MECHANISM OTHER THAN THE RENIN SYSTEM CAUSES SODIUM RETENTION IN NEPHROTIC SYNDROME

E. Brown, N. Markandu, G. Sagnella, 1982, The Lancet.

Subcellular distribution of low- and high-molecular-weight renin and its relation to a renin inhibitor in pig renal cortex.

G. Sagnella, P. R. Caldwell, W. Peart, 1980, Clinical science.

Frequency and allelic association of common variants in the lipoprotein lipase gene in different ethnic groups: The Wandsworth Heart and Stroke Study

D. Cook, P. Talmud, F. Cappuccio, 2000, Genetic epidemiology.

Measurement and significance of circulating natriuretic peptides in cardiovascular disease.

G. Sagnella, 1998, Clinical science.

Effects of amlodipine on urinary sodium excretion, renin-angiotensin-aldosterone system, atrial natriuretic peptide and blood pressure in essential hypertension.

F. Cappuccio, N. Markandu, G. Sagnella, 1991, Journal of human hypertension.

Risk of Cardiac Arrhythmia Variant of SCN 5 A Sodium Channel Implicated in

F. Cappuccio, A. Beggs, R. Kass, 2007 .

[Different effect of nifedipine in normotensive and hypertensive individuals: a functional anomaly of vascular smooth muscle in essential hypertension?].

N. Markandu, G. Sagnella, G. MacGregor, 1983, Revista espanola de cardiologia.

Ethnic differences in circulating soluble adhesion molecules: the Wandsworth Heart and Stroke Study.

D. Cook, F. Cappuccio, S. Kerry, 2003, Clinical science.

Dissociation between plasma atrial natriuretic peptide levels and urinary sodium excretion after intravenous saline infusion in normal man.

A. Shore, N. Markandu, G. Sagnella, 1987, Clinical science.

Homocysteine levels in men and women of different ethnic and cultural background living in England.

D. Cook, F. Cappuccio, I. Perry, 2002, Atherosclerosis.

Ecf - every reason for presence of interacting multiple homeostatic control mechanisms

G. Sagnella, G. MacGregor, 1985 .

Structural and functional features of atrial natriuretic peptides

G. Sagnella, G. MacGregor, 1986 .

Validation of echocardiographic left atrial parameters in atrial fibrillation using the index beat of preceding cardiac cycles of equal duration.

J. Camm, B. Bijnens, G. Sagnella, 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

Studies on the isolation and properties of renin granules from the rat kidney cortex.

G. Sagnella, W. Peart, 1979, Biochemical Journal.

Model fitting, parameter estimation, linear and non-linear regression

G. A. Sagnella, G. Sagnella, 1985 .

Are the atrial peptides a natriuretic hormone?

G. Sagnella, G. MacGregor, 1987, European Heart Journal.

Does Moderate Dietary Sodium Restriction Lower Blood Pressure in Essential Hypertension? a Double Blind Randomised Cross over Trial Using Slow Sodium and Placebo

N. Markandu, G. Sagnella, G. MacGregor, 1982 .

Raised Plasma Levels of Atrial Natriuretic Peptide in Untreated Essential Hypertension

A. Shore, N. Markandu, G. Sagnella, 1986 .

Contrasting effects of nifedipine, captopril, and propranolol in normotensive and hypertensive subjects.

N. Markandu, G. Sagnella, G. MacGregor, 1982, Journal of cardiovascular pharmacology.

Journal ClubAuthors' reply:

Yanbin Dong, G. Sagnella, G. MacGregor, 1999 .

The acute response to nifedipine is related to pre-treatment blood pressure.

N. Markandu, G. Sagnella, G. MacGregor, 1983, Postgraduate medical journal.

Long term reduction in sodium balance: possible additional mechanism whereby nifedipine lowers blood pressure.

F. Cappuccio, N. Markandu, G. Sagnella, 1990, BMJ.

Effects of synthetic atrial natriuretic peptides on sodium-potassium transport in human erythrocytes.

A. Shore, G. Sagnella, G. MacGregor, 1985, Clinical science.

ATRIAL NATRIURETIC PEPTIDE, BLOOD PRESSURE, AND AGE

N. Markandu, G. Sagnella, G. MacGregor, 1987, The Lancet.

Plasma acidification increases atrial natriuretic peptide as measured by radioimmunoassay.

G. Sagnella, G. MacGregor, M. Buckley, 1987, Clinical chemistry.

Variant of SCN5A Sodium Channel Implicated in Risk of Cardiac Arrhythmia

F. Cappuccio, A. Beggs, R. Kass, 2002, Science.

The effect of oral digoxin on sodium excretion, renin-angiotensin-aldosterone system and blood pressure in normotensive subjects.

F. Cappuccio, N. Markandu, G. Sagnella, 1986, Postgraduate medical journal.